General introduction to innate immunity: Dr. Jekyl/Mr. Hyde quality of the innate immune system

Contributions to Microbiology

Volumn 15, Issue , 2008, Pages 12-20

  Zanker K ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; TOLL LIKE RECEPTOR;

ANIMAL; CHEMISTRY; COMPLEMENT ACTIVATION; DENDRITIC CELL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; INNATE IMMUNITY; NEUTROPHIL; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; COMPLEMENT ACTIVATION; DENDRITIC CELLS; HUMANS; IMMUNE SYSTEM; IMMUNITY, NATURAL; LECTINS, C-TYPE; NEUTROPHILS; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

ANIMALIA; INVERTEBRATA; MAMMALIA; VERTEBRATA;

EID: 49449112440     PISSN: 14209519     EISSN: 1662291X     Source Type: Book Series    
DOI: 10.1159/000135683     Document Type: Review

References (42)

1. Kimbrell DA, Beutler B: The evolution and genetics of innate immunity. Nat Rev Genet 2001;2:256-267.
2. Danilova N: The evolution of immune mechanisms. J Exp Zoolog B Mol Dev Evol 2006;306:496-520.
3. Steinmann RM: Linking innate to adaptive immunity through dendritic cells. Novartis Found Symp 2006;279:101-109; discussion 109-113, 216-219.
4. Kemper C, Atkinson JP: T-cell regulation: with complements from innate immunity. Nat Rev Immunol 2007;7:9-18.
5. Hoebe K, Jiang Z, Tabeta K, Du X, Georgel P, Crozat K, Beutler B: Genetic analysis of innate immunity. Adv Immunol 2006;91:175-226.
6. Albiger B, Dahlberg S, Henriques-Normark B, Normark S: J Intern Med 2007;261:511-528.
7. Borghesi L, Milcarek C: Innate versus adaptive immunity: a paradigm past its prime? Cancer Res 2007;67:3989-3993.
8. Romagne F: Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors. Drug Discov Today 2007;12:80-87.
9. Cristofaro P, Opat SM: Role of Toll-like receptors in infection and immunity: clinical implications. Drugs 2006;66:15-29.
10. Kanzler H, Barrat FJ, Hessel EM, Hoffman R: Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007;13:552-559.
11. Danese S, Dejana E, Fiocchi C: Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 2007;178:6017-6022.
12. Uematsu S, Akira S: Toll-like receptors and Type I Interferons. J Biol Chem 2007;282:15319-15323.
13. Sheen J, He P: Nuclear actions in innate immune signaling. Cell 2007;128:821-823.
14. Trinchieri G, Sher A: Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007;7:179-190.
15. Vollmer J: CpG motifs to modulate innate and adaptive immune response. Int Rev Immunol 2006;25:125-134.
16. Larosa DF, Rahman AH, Turka LA: The innate immune system in allograft rejection and tolerance. J Immunol 2007;178:7503-7509.
17. Ghiringhelli F, Apetoh L, Housseau F, Kroemer G, Zitvogel L: Links between innate and cognate tumor immunity. Curr Opin Immunol 2007;19:224-231.
18. Lin WW, Karin M: A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007;117:1175-1183.
19. Guan R, Mariuzza RA: Peptidoglycan recognition proteins of the innate immune system. Trends Microbiol 2007;15:127-134.
20. McGreal EP, Martinez-Pomares L, Gordon S: Divergent roles for C-type lectins expressed by cells of the innate immune system. Mol Immunol 2004;41:1109-1121.
21. Gijzen K, Gambi A, Torensma R, Figdor CG: C-type lectins on dendritic cells and their interaction with pathogen-derived and endogenous glycoconjugates. Curr Protein Pept Sci 2006;7:283-294.
22. Zhou T, Chen Y, Hao L, Zhang Y: DC-SIGN and immunoregulation. Cell Mol Immunol 2006;3:279-283.
23. Bhardwaj N: Harnessing the immune system to treat cancer. J Clin Invest 2007;117:1130-1136.
24. Van Kooyk Y, Engering A, Lekkerkerker AN, Ludwig IS, Geijtenbeek TB: Pathogens use carbohydrates to escape immunity induced by dendritic cells. Curr Opin Immunol 2004;16:488-493.
25. Barreiro LB, Neyrolles O, Babb Cl, Tailleux L, Quach H, McElreavey K, Helden PD, Hoal EG, Gicquel B, Quintana-Murci L: Promoter variation in the DC-SIGN-encoding gene CD209 is associated tuberculosis. PloS Med 2006;3:e20.
26. Sakuntabhai A, Turbpaiboon C, Casademont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A, Kalayanarooj SM, Tangnararatchakit K, Tangthawornchaikul N, Vasanawathana S, Chaiyaratana W, Yenchitsomanus PT, Suriyaphol P, Avirutnan P, Chokephaibulkit K, Matsuda F, Yoksan S, Jacob Y, Lathrop gM, Malasit P, Despres P, Julier C: A variant in the CD209 promotor is associated with severity of dengue disease. Nat Genet 2005;37:507-513.
27. Pyz E, Marshall AS, Gordon S, Brown GD: C-type lectin-like receptors on myeloid cells. Ann Med 2006;38:242-251.
28. Reis ES, Barbuto JA, Isaac L: Complement components, regulators and receptors are produced by human monocyte-derived dendritic cells. Immunobiology 2007;212:151-157.
29. Pisetsky DS: The role of nuclear macromolecules in innate immunity. Proc Am Thorac Soc 2007;4:258-262.
30. Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T, Lu Y, Miyagishi M, Kondama T, Honda K, Ohba Y, Taniguchi T: DAI (DLM/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 2007;448:501-505.
31. Yan M, Di Ciano-Oliveira C, Grinstein S, Trimble WS: Coronin function is required for chemotaxis and phagocytosis in human neutrophils. J Immunol 2007;178:5769-5778.
32. Entschladen F, Zänker KS: Locomotion of tumor cells: a molecular comparison to migrating pre- and postmitotic leukocytes. J Cancer Res Clin Oncol 2000;126:671-681.
33. Nakano T, Tahara-Hanaoka S, Nahahashi C, Can I, Totsuka N, Honda SI, Shibuya K, Shibuya A: Activation of neutrophils by a novel triggering immunoglobulin-like receptor MAIR-IV. Mol Immunol 2008;45:289-294.
34. Borregaard N, Sorensen OE, Theilgaard-Monch K: Neutrophil granules: a library of innate immunity proteins. Trends Immunol 2007;28:340-345.
35. Prohaszka Z: Chaperones as part of the immune networks. Adv Exp Med Biol 2007;594:159-166.
36. Metz M, Maurer M: Mast cells - key effector cells in immune response. Trends Immunol 2007;28:234-241.
37. Farina C, Aloisi F, Meinl E: Astrocytes are active players in cerebral innate immunity. Trends Immunol 2007;28:138-145.
38. Shiraki R, Inoue N, Kawasaki S, Takei A, Kadotani M, Ohnishi Y, Ejiri J, Kobayashi S, Hirata K, Kawashima S, Yokoyama M: Expression of Toll-like receptors on human platelets. Thromb Res 2004;113:379-385.
39. Tsujimoto T, Kuriyama S, Yamazaki M, Nakatani Y, Okuda H, Yoshiji H, Fukui H: Augmented hepatocellular carcinoma progression and depressed Kupffer cell activity in rat cirrhotic livers. Int J Oncol 2001;18:41-47.
40. Lugini L, Matarrese P, Tinari A, Lozupone F, Federici C, Iessi E, Gentile M, Luciani F, Parmiani G, Rivoltini L, Malorni W, Fais S: Cannibalism of liver lymphocytes by human metastatic but not primary melanom cells. Cancer Res 2006;66:3629-3638.
41. Sioud M: RNA interference and innate immunity. Adv Drug Deliv Rev 2007;59:153-163.
42. Dittmar T, Zaenker KS, Schmidt A (eds): Infection and Inflammation. Impacts on Oncogenesis. Contrib Microbiol. Basel, Karger, 2006, vol 13.